ClearPoint Neuro, Inc.
CLPT
DELAYED 1 MONTH

29 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 2 8:30 PMTimothy T. RichardsDirector
Sale
5,415$12.17$65.9K87,198(D)

View →

May 21, 2026May 26 8:30 PMMatthew B. KleinDirector
Sale
16,000$11.59$185.4K46,935(D)

View →

May 20, 2026May 21 8:30 PMLynnette C FallonDirector
Sale
5,091$11.14$56.7K48,227(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 6, 2026Mar 10 9:03 PMJoseph BurnettDirector, CEO and President
Option Exercise
47,407—0(D)

View →

Mar 6, 2026Mar 10 9:00 PMJeremy L. StigallChief Business Officer
Option Exercise
17,778—0(D)

View →

Mar 6, 2026Mar 10 8:57 PMMazin SabraChief Operating Officer
Option Exercise
13,827—0(D)

View →

Mar 6, 2026Mar 10 8:55 PMDanilo D'AlessandroChief Financial Officer
Option Exercise
18,765—0(D)

View →

Mar 3, 2026Mar 5 9:48 PMJoseph BurnettDirector, CEO and President
Option Exercise
26,568—106,273(D)

View →

Mar 3, 2026Mar 5 9:46 PMDanilo D'AlessandroChief Financial Officer
Option Exercise
10,332—41,328(D)

View →

Mar 3, 2026Mar 5 9:43 PMJeremy L. StigallChief Business Officer
Option Exercise
8,856—35,424(D)

View →

Mar 3, 2026Mar 5 9:25 PMMazin SabraChief Operating Officer
Option Exercise
6,642—26,568(D)

View →

← Previous

Page 2 of 2